Publications by authors named "O O Adejumo"

Background: Clients with substance use disorders (SUDs) have a substantial risk of developing Type 2 diabetes mellitus (T2DM). The connection between SUD and DM stems from rapid cell damage, pancreatic beta-cell dysfunction, and glucose dysregulation due to increased oxidative stress and decreased antioxidant activity. This study aims to reduce the risk of T2DM among individuals undergoing SUD recovery treatments.

View Article and Find Full Text PDF

This study investigates the effect of a nationwide maternal health programme that targets both demand- and supply-side factors on the nutritional status of children under five years old whose mothers were potentially exposed to the programme. We employed a difference-in-differences approach by matching programme beneficiary facilities to the districts and communities where households reside. The data are drawn from the 2008, 2013, and 2018 rounds of Nigeria's Demographic and Health Surveys (DHS), comprising responses for approximately 120,000 children.

View Article and Find Full Text PDF
Article Synopsis
  • Dyslipidaemia is a major contributor to coronary artery disease (CAD) and cardiovascular issues globally, and understanding statin benefits is essential for its effective management.
  • A web-based survey involving 313 physicians in Nigeria revealed that while most recognize elevated LDL-C as a key cause of CAD, many have concerns about statin side effects and their impact on patient adherence.
  • The findings indicate significant knowledge and practice gaps in dyslipidaemia management among Nigerian physicians, suggesting a need for improvement initiatives to reduce cardiovascular risk.
View Article and Find Full Text PDF

Background: This study assessed the moderating effect of social support on the association between experienced stigma versus anxiety, depression and loneliness among people with drug-resistant tuberculosis.

Methods: A descriptive cross-sectional study was conducted among 203 adults on treatment for drug-resistant tuberculosis for at least 8 weeks. Validated scales were used to assess experienced stigma, anxiety, depression, loneliness and social support.

View Article and Find Full Text PDF